Arena Pharmaceuticals About
Arena Pharmaceuticals Their
proprietary technologies include their constitutively activated receptor technology
(“CART”) and Melanophore technology, which they believe will allow them to discover
drug-like compounds more efficiently and effectively than other assay methods Arena's
focus is on discovering and developing drugs to targets in the following therapeutic
areas: Cardiovascular — Atherosclerosis
and Heart Disease Central Nervous System — Sleep
Disorders; Schizophrenia;
Depression and Anxiety; Neurodegeneration Inflammation —
Inflammatory Bowel Disease and Asthma
More
on Arena Pharmaceuticals
Arena
Pharmaceuticals, Inc. (NASDAQ: ARNA), is a biopharmaceutical company involved
in research and development, at our research campus in the
field of G protein-coupled receptors (“GPCRs”).
Home Page for Arena Pharmaceuticals